Milford, United States
SeraCare, a pioneering entity within LGC's Clinical Diagnostics Division, exemplifies impactful innovation in the field of precision medicine. Established in 1984, the company is headquartered in the United States and operates at the intersection of Biotechnology, Health Care, and Pharmaceutical industries.
Under the guiding principle of their slogan, "LGC Clinical Diagnostics | Science for a Safer World", SeraCare provides advanced tools and technologies that not only enhance the diagnostic process but also set standards for regulating precision diagnostics. Their diverse product portfolio includes quality control technologies and disease-state specimens, offering robust solutions for research and development.
The absence of recent funding details might suggest stable internal revenue generation, yet it signals potential growth opportunities for investors looking to support innovation in diagnostics. With a legacy spanning decades, SeraCare stands as a reliable player capable of driving advancements in sector-specific technologies and health outcomes.
